Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2012
Earnings Release and Conference Call
WILMINGTON, Mass. -- January 22, 2013
Charles River Laboratories International, Inc. (NYSE: CRL) will release
fourth-quarter and full-year 2012 financial results on Wednesday, February
13^th, after the market closes. A conference call has been scheduled to
discuss this information on Thursday, February 14^th, at 8:30 a.m. EST.
Investors will have the opportunity to listen to a live webcast of the
conference call through the Investor Relations section of the Company's
website at ir.criver.com. A replay will be accessible through the same
About Charles River
Accelerating Drug Development. Exactly. Charles River provides essential
products and services to help pharmaceutical and biotechnology companies,
government agencies and leading academic institutions around the globe
accelerate their research and drug development efforts. Our dedicated
employees are focused on providing clients with exactly what they need to
improve and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To learn more
about our unique portfolio and breadth of services, visit www.criver.com.
Investor Relations Contact:
Charles River Laboratories International, Inc.
Susan E. Hardy, 781-222-6190
Corporate Vice President, Investor Relations
Press spacebar to pause and continue. Press esc to stop.